Trial ID or NCT#
Solid organ transplantation is an important therapeutic option for children with a variety of end stage diseases. However, the same immunosuppressive medications that are required to prevent the child's immune system from attacking and rejecting the transplanted organ can predispose these individuals to developing a very serious cancer that is linked to Epstein-Barr virus (EBV).
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Contact us to find out if this trial is right for you.
Sheri Krams, PhD